Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular side effects associated with bisphosphonates.

Frederick W Fraunfelder1

  • 1National Registry of Drug-Induced Ocular Side Effects, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97201-4197, USA. eyedrug@uhsu.edu

Drugs of Today (Barcelona, Spain : 1998)
|January 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Tolerability and Safety of AAV5-Id3 Gene Therapy to Eyes.

Translational vision science & technology·2026
Same author

Open-Field Blast Injury Disrupts Corneal Gene Expression Linked to Ion Transport, Sensory Perception, and Neural Signaling.

Investigative ophthalmology & visual science·2025
Same author

Possible Association Between Apremilast Therapy and Increased Tearing.

Ophthalmic plastic and reconstructive surgery·2020
Same author

Vaccine-Associated Uveitis.

Ocular immunology and inflammation·2019
Same author

Liquid Nitrogen Cryotherapy Treatment of Herpes Simplex Epithelial Keratitis.

Missouri medicine·2018
Same author

Oral Anti-Vascular Endothelial Growth Factor Drugs and Ocular Adverse Events.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2018

Bisphosphonates, used for bone health, can cause inflammatory ocular side effects like scleritis. Discontinuation of these drugs often resolves these adverse events, prompting ophthalmic evaluation.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Oncology

Background:

  • Bisphosphonates are critical for managing bone resorption in postmenopausal women and hypercalcemia in malignancy.
  • Ocular side effects associated with bisphosphonates, primarily inflammatory, have been increasingly reported.
  • Scleritis has recently emerged as a significant ocular adverse event linked to this drug class.

Purpose of the Study:

  • To review bisphosphonate medications and their associated ocular side effect profiles.
  • To highlight the range of ocular adverse events linked to bisphosphonate therapy.
  • To emphasize the importance of recognizing and managing bisphosphonate-induced ocular complications.

Main Methods:

  • Literature review of bisphosphonates and their ocular side effects.

Related Experiment Videos

  • Analysis of reported cases of ocular inflammation associated with bisphosphonate use.
  • Examination of dechallenge data to assess reversibility of ocular side effects.

    • Main Results:

    • Bisphosphonates are associated with various ocular side effects, predominantly inflammatory.
    • Scleritis is a notable adverse event linked to certain bisphosphonate drugs.
    • Ocular side effects typically resolved upon discontinuation of bisphosphonate therapy (dechallenge).

    Conclusions:

    • Clinicians should be aware of the potential for bisphosphonate-induced ocular adverse events, including scleritis.
    • Ophthalmic evaluation is crucial for patients experiencing ocular symptoms during bisphosphonate therapy.
    • Discontinuation of bisphosphonate medication should be considered for all cases of scleritis.